Surgical outcome and long-term follow up after laparoscopic rectosigmoid resection in women with deep infiltrating endometriosis.

The aim of this study was to assess the long-term outcome of treating severely symptomatic women with deep infiltrating intestinal endometriosis by laparoscopic segmental rectosigmoid resection. Detailed intraoperative and postoperative records and questionnaires (preoperatively, 1 month postoperatively and every 6 months for 3 years) were collected from 22 women. The estimated blood loss during surgery was 290 +/- 162 ml (range 180-600), and average hospital stay was 8 days (range 6-19).

Obstetric and delivery outcome of pregnancies achieved after laparoscopic myomectomy.

Objective: To assess the risks and outcome of pregnancies and deliveries after laparoscopic myomectomy (LM).

Design: Retrospective study.

Setting: Center of Reconstructive Pelvic Endosurgery, Reproductive Medicine Unit, S.

GnRH agonist treatment before total laparoscopic hysterectomy for large uteri.

Study Objective: To evaluate whether uterine shrinkage induced by gonadotropin-releasing hormone (GnRH) agonists in women with a large uterus (>14 wks) may facilitate total laparoscopic hysterectomy.

Design: Randomized, prospective study (Canadian Task Force classification I).

Setting: University-affiliated hospital.

Total laparoscopic hysterectomy compared with abdominal hysterectomy in the presence of a large uterus.

Study Objective: To evaluate in a prospective series whether, even in presence of a large uterus, total laparoscopic hysterectomy is feasible and safe, and may be substituted for abdominal hysterectomy.

Design: Randomized comparison (Canadian Task Force classification I). Setting.

Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism.

Objective: To evaluate the safety and efficacy of a low dose of flutamide (125 mg/day) in maintaining the clinical results already obtained using a higher dose (250 mg/day), in women suffering from hirsutism.

Method: Forty-three women suffering from hirsutism of varying origin received 250 mg/day of flutamide as an initial treatment for 12 months and, subsequently, 125 mg/day of flutamide for an additional 12 months as a maintenance treatment. Hirsutism was evaluated by the Ferriman-Gallwey score, and hair diameter and hair growth rate were determined by a special image analysis processor.